Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies.

Tam CS, Anderson MA, Simkovic M, Ghia P, Flinn IW, Laribi K, Opat SS, Cull G, Munir T, Österborg A, Tedeschi A, Wang MY, Szeto AH, Allewelt H, Salmi T, Li J, Xu L, Wu K, Vezan R, Shadman M, Brown JR

Accelerating risk: a qualitative evidence synthesis on facilitators and barriers to speeding.

Singh P, Bhaumik S, Brown J, Jagnoor J

A new time tree of birds reveals the interplay between dispersal, geographic range size, and diversification.

Claramunt S, Sheard C, Brown JW, Cortés-Ramírez G, Cracraft J, Su MM, Weeks BC, Tobias JA

Association of injury-related mortality with unique domains of social determinants of health across the urban-rural continuum.

Byrd T, Kass N, Lu L, Silver D, Boland S, Brown JB

Effects of prior self-control exertion on breathing effort during inspiratory loading.

Johnson MA, Sharpe GR, Brown JC, Boat R

Coordinated Development of Immune Cell Populations in Vascularized Skin Organoids from Human Induced Pluripotent Stem Cells.

Mostina M, Sun J, Sim SL, Ahmed IA, Souza-Fonesca-Guimaraes F, Wolvetang EJ, Brown J, Kumari S, Khosrotehrani K, Shafiee A

Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications.

AlJabban A, Azevedo RS, Antel K, Arnette A, Cohen EF, Meredith DM, Murakami MA, Sholl LM, Tolstorukov MY, Tsai HK, Tsai JM, Zemmour D, Lindeman NI, Garcia E, Brown JR, Kim AS

Optimizing treatment for metastatic castration-resistant prostate cancer: Food and Drug Administration-approved therapies, emerging strategies, and biomarker-driven approaches.

Saeed F, Berchuck JE, Bilen MA, Gandhi JS, Nazha B, Brown JT, Schuster DM, Jani AB, Yu J, Harik LR

First Complete Genome Sequence of Palo Verde Broom Emaravirus, Virus-Derived siRNA Signatures, and Phytohormone-Metabolite Profiling of Witches' Broom-Affected Palo Verde Trees.

Adegbola RO, Ilyas M, Maheepala DC, Schuch UK, Brown JK

It's "Blin" a Long Time Coming: The Rise of Blinatumomab in Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.

Shinn LT, King MA, Brown J, Fraga MS, Benitez LL, Marini BL, Perissinotti AJ